BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25151211)

  • 1. Cardiomyopathy associated with cancer therapy.
    Yu AF; Steingart RM; Fuster V
    J Card Fail; 2014 Nov; 20(11):841-52. PubMed ID: 25151211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced cardiomyopathy.
    Higgins AY; O'Halloran TD; Chang JD
    Heart Fail Rev; 2015 Nov; 20(6):721-30. PubMed ID: 26338137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging.
    Bloom MW; Hamo CE; Cardinale D; Ky B; Nohria A; Baer L; Skopicki H; Lenihan DJ; Gheorghiade M; Lyon AR; Butler J
    Circ Heart Fail; 2016 Jan; 9(1):e002661. PubMed ID: 26747861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies.
    López-Fernández T; Thavendiranathan P
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):487-495. PubMed ID: 28189542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.
    O'Hare M; Sharma A; Murphy K; Mookadam F; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):511-8. PubMed ID: 25843285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential usefulness of diastolic parameters measured by strain imaging echocardiography in the early prediction of chemotherapy-induced cardiotoxicity.
    Hernandez-Suarez DF; López-Candales A
    Med Hypotheses; 2017 Apr; 101():30-32. PubMed ID: 28351486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced cardiomyopathy.
    Yusuf SW; Ilias-Khan NA; Durand JB
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):231-43. PubMed ID: 21506294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.
    Lipshultz SE; Diamond MB; Franco VI; Aggarwal S; Leger K; Santos MV; Sallan SE; Chow EJ
    Paediatr Drugs; 2014 Oct; 16(5):373-89. PubMed ID: 25134924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Toxicities in Pediatric Cancer Survivors.
    Ryan TD; Nagarajan R; Godown J
    Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity of cancer chemotherapy: implications for children.
    Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE
    Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician.
    Dillenburg RF; Nathan P; Mertens L
    Eur J Pediatr; 2013 Sep; 172(9):1149-60. PubMed ID: 23361962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyopathy Prevention in Cancer Patients.
    Barbar T; Mahmood SS; Liu JE
    Cardiol Clin; 2019 Nov; 37(4):441-447. PubMed ID: 31587785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chemotherapy-associated cardiomyopathy.
    Cai AW; Taylor MH; Ramu B
    Curr Opin Cardiol; 2019 May; 34(3):296-302. PubMed ID: 30747732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy.
    Mukku RB; Fonarow GC; Watson KE; Ajijola OA; Depasquale EC; Nsair A; Baas AS; Deng MC; Yang EH
    J Card Fail; 2016 Jun; 22(6):439-48. PubMed ID: 27109619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention and management of cardiovascular complications of chemotherapy in patients with cancer.
    Youssef G; Links M
    Am J Cardiovasc Drugs; 2005; 5(4):233-43. PubMed ID: 15984906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracycline-Induced Cardiotoxicity in Young Cancer Patients: The Role of Carnitine.
    Armenian SH
    Ann Nutr Metab; 2016; 68 Suppl 3():10-14. PubMed ID: 27931027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Chemotherapy Induced Cardiomyopathy.
    Payne DL; Nohria A
    Curr Heart Fail Rep; 2017 Oct; 14(5):398-403. PubMed ID: 28779279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized Approach to Cancer Treatment-Related Cardiomyopathy.
    Slivnick J; Vallakati A; Addison D; Wallner A; Tong MS
    Curr Heart Fail Rep; 2020 Apr; 17(2):43-55. PubMed ID: 32125627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roadmap for biomarkers of cancer therapy cardiotoxicity.
    Yu AF; Ky B
    Heart; 2016 Mar; 102(6):425-30. PubMed ID: 26674989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Dysfunction in Cancer Treatment: Is it Relevant?
    Kenigsberg B; Wellstein A; Barac A
    JACC Heart Fail; 2018 Feb; 6(2):87-95. PubMed ID: 29413379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.